Description
The purpose of this Notice of Amendment is to notify about the additions of the following medicinal ingredients on the Prescription Drug List (PDL) for human and veterinary use: Brexucabtagene autoleucel; Idecabtagene vicleucel; Pitolisant; Risdiplam; Selpercatinib; Solriamfetol; Tepotinib; Tildrakizumab; Trastuzumab; deruxtecan.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Notice: Prescription Drug List (PDL): Multiple Additions (2021-07-23) | HTML | Open resource | |
| Notice: Prescription Drug List (PDL): Multiple Additions (2021-07-23) | HTML | Open resource |